Important prognostic factors for survival in patients with malignant pleural effusion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Important prognostic factors for survival in patients with malignant pleural effusion

Published:2015-03-28 Issue:1 Volume:15 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Zamboni Mauro Musa,da Silva Cyro Teixeira,Baretta Rodrigo,Cunha Edson Toscano,Cardoso Gilberto Perez

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/article/10.1186/s12890-015-0025-z/fulltext.html

Reference44 articles.

1. Froudarakis ME. Pleural effusion in lung cancer: more questions than answers. Respiration. 2012;83(5):367–76.

2. Chernow B, Sahn SA. Carcinomatous involvement of the pleura. An analysis of 96 patients. Am J Med. 1977;63(5):695–702.

3. Haas AR, Sterman DH, Musani AI. Malignant pleural effusions - management options with consideration of coding, billing, and a decision approach. Chest. 2007;132(3):1036–41.

4. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ. Management of a malignant pleural effusion: British thoracic society pleural disease guideline 2010. Thorax. 2010;65 Suppl 2:ii32–40.

5. Light RW. Pleural diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013.

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palliative Care for Patients With Breast Cancer in a Palliative Care Unit of a Japanese Hospital;Cureus;2024-08-26

2. A common secretomic signature across epithelial cancers metastatic to the pleura supports IL-6 axis therapeutic targeting;Frontiers in Immunology;2024-07-24

3. Management des malignen Pleuraergusses;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-06

4. The association between frailty and survival in patients with pleural disease: a retrospective cohort study;BMC Pulmonary Medicine;2024-04-16

5. Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study;BMC Cancer;2024-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3